Cencora Inc
General ticker "COR" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $47.1B
Cencora Inc follows the US Stock Market performance with the rate: 23.4%.
Estimated limits based on current volatility of 0.8%: low 224.67$, high 228.20$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends: last record date 2024-11-15, amount 0.55$ (Y0.97%)
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-09-30 to 2026-09-30
- 2024-09-30 to 2025-09-30 estimated range: [190.87$, 273.31$]
- 2025-09-30 to 2026-09-30 estimated range: [190.74$, 277.56$]
Financial Metrics affecting the COR estimates:
- Negative: Operating profit margin, % of 0.74 <= 1.03
- Positive: Non-GAAP EPS, $ of 13.76 > 2.29
- Positive: -0.25 < Return on assets ratio (scaled to [-100,100]) of 2.20
- Positive: Industry operating cash flow per share per price (median), % of 10.63 > 10.07
- Positive: 7.18 < Operating cash flow per share per price, % of 7.48
- Negative: Industry operating profit margin (median), % of 0.64 <= 2.14
- Negative: Interest expense per share, $ of 0.79 > 0.74
Short-term COR quotes
Long-term COR plot with estimates
Financial data
YTD | 2022-09-30 | 2023-09-30 | 2024-09-30 |
---|---|---|---|
Operating Revenue | $238,587.01MM | $262,173.41MM | $293,958.60MM |
Operating Expenses | $236,220.63MM | $259,832.68MM | $291,783.35MM |
Operating Income | $2,366.38MM | $2,340.73MM | $2,175.25MM |
Non-Operating Income | $-183.32MM | $-179.90MM | $-171.27MM |
Interest Expense | $210.67MM | $228.93MM | $156.99MM |
Income(Loss) | $2,183.06MM | $2,160.84MM | $2,003.97MM |
Taxes | $484.24MM | $415.54MM | $494.86MM |
Profit(Loss) | $1,698.82MM | $1,745.29MM | $1,509.12MM |
Stockholders Equity | $-289.78MM | $666.29MM | $645.94MM |
Inventory | $15,556.39MM | $17,454.77MM | $20,174.70MM |
Assets | $56,482.39MM | $62,558.75MM | $67,101.67MM |
Operating Cash Flow | $2,703.09MM | $3,911.33MM | $3,484.68MM |
Capital expenditure | $496.32MM | $458.36MM | $487.17MM |
Investing Cash Flow | $-368.44MM | $-2,602.47MM | $-618.10MM |
Financing Cash Flow | $-1,752.78MM | $-2,222.28MM | $-2,330.99MM |
Earnings Per Share* | $8.15 | $8.62 | $7.60 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.